adipose-derived mesenchymal stem cell therapy (Rohto Pharmaceutical)

N/A

Report date: 2025/03/14 16:40:22

Base Information

Drug Nameadipose-derived mesenchymal stem cell therapy (Rohto Pharmaceutical)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCorneal Ulcer

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryJapan

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesRohto Pharmaceutical Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesRohto Pharmaceutical Co Ltd

Inactive CompaniesN/A

Active IndicationsCorneal Ulcer

Inactive IndicationsN/A

Other Information

ATC CodeN/A